Bio + Nano + Ark is an alliance to augment the growth of Biotechnology and Nanotechnology in Arkansas.
We hope to support industry, academic and regulatory collaborations that could provide the following:
• Bio-nano Integrated Assay Development
• Smart drug delivery to improve a drug's therapeutic potential by targeting specific sites in previously impossible locations.
• Bio Sensors and systems to detect disease in the body for early detection
• Acceleration of genome sequencing
• Novel gene therapy approaches to disease
• Revolutionary diagnostics and therapeutics
• Nano characterization of the internal structure of cells
• Determine bionano applications to utilize materials and molecular machines found in living systems.
• Bionano biologicals and materials to regenerate tissues and organs
• Bio-nano Integrated Assay Development
• Smart drug delivery to improve a drug's therapeutic potential by targeting specific sites in previously impossible locations.
• Bio Sensors and systems to detect disease in the body for early detection
• Acceleration of genome sequencing
• Novel gene therapy approaches to disease
• Revolutionary diagnostics and therapeutics
• Nano characterization of the internal structure of cells
• Determine bionano applications to utilize materials and molecular machines found in living systems.
• Bionano biologicals and materials to regenerate tissues and organs
Why Arkansas?
Arkansas is uniquely situated at the intersection of biotechnology and nanotechnology; which is the intersection of biological materials with particles that are 10,000 times smaller than a strand of human hair, or 10,000 times smaller than an ordinary living cell. The intersection of Bionano material allows creation of smart particles to target specific parts of the body or even a precise element of a single cell. Why Arkansas? The state of Arkansas has a unique advantage over other states- The National Center for Toxicological Research.
“The National Center for Toxicological Research (NCTR), is the only FDA Center located outside the Washington D.C. metropolitan area. The one-million square foot research campus in Jefferson, Arkansas plays a critical role in the missions of FDA and the Department of Health and Human Services to promote and protect public health. Regulatory science researchers, academia, and other regulatory science research organizations and groups from around the world investigate, learn, and train at the Federal facility. NCTR, FDA's internationally recognized research center, plays a critical role in FDA’s mission. The unique scientific expertise of NCTR is critical in supporting FDA product centers and their regulatory roles.”
Arkansas is the beneficiary of NCTR’s inherent transfer of technology and an infusion of a technology culture. NCTR has established the NCTR/ORA Nanotechnology Core Facility to review the use of nanoscale materials in drugs, devices, biologics, cosmetics, and food.
“The newly created NCTR/ORA Nanotechnology Core Facility supports nanotechnology toxicity studies, develops analytical tools to quantify nanomaterials in complex matrices, and develops procedures for characterizing namomaterials in FDA-regulated products.”
The State of Arkansas further bolstered the industries when the State of Arkansas legislated the establishment of the Arkansas Biosciences Institute (ABI) as a consortium of five research institutions: Arkansas Children’s Hospital (ACH); Arkansas State University (ASU); the University of Arkansas Division of Agriculture; the University of Arkansas, Fayetteville (UAF); and the University of Arkansas for Medical Sciences (UAMS).
One of the other efforts to bolster the industries was the establishment of the “Institute for Nanoscience & Engineering” research facility located on the University of Arkansas campus. The Institute comprises interdisciplinary departments across campus working in nanoscale research. Capabilities include materials growth and characterization, protein transportation, nano-bio photonics, theoretical modeling, tribology, and materials manufacturing. Successful federal funding, industry collaboration and support, and recruiting top notch faculty and students: For these reasons and more, the University of Arkansas Institute for Nanoscience & Engineering is at the forefront of research in nanoscience and nanotechnology.
Subsequently, the Institute for Nanoscience & Engineering established the “Arkansas Nano-Bio Materials Characterization Facility”. “The Facility provides state-of-art analytical services to the University and community with its high-resolution imaging, spectroscopy or sample preparation capabilities. The scientific activities cover a wide range of discipline ranging from Physics to Bio-Engineering and are aimed at supporting University research through the analysis of Nano and Bio materials properties down to the atomic scale.”
“The National Center for Toxicological Research (NCTR), is the only FDA Center located outside the Washington D.C. metropolitan area. The one-million square foot research campus in Jefferson, Arkansas plays a critical role in the missions of FDA and the Department of Health and Human Services to promote and protect public health. Regulatory science researchers, academia, and other regulatory science research organizations and groups from around the world investigate, learn, and train at the Federal facility. NCTR, FDA's internationally recognized research center, plays a critical role in FDA’s mission. The unique scientific expertise of NCTR is critical in supporting FDA product centers and their regulatory roles.”
Arkansas is the beneficiary of NCTR’s inherent transfer of technology and an infusion of a technology culture. NCTR has established the NCTR/ORA Nanotechnology Core Facility to review the use of nanoscale materials in drugs, devices, biologics, cosmetics, and food.
“The newly created NCTR/ORA Nanotechnology Core Facility supports nanotechnology toxicity studies, develops analytical tools to quantify nanomaterials in complex matrices, and develops procedures for characterizing namomaterials in FDA-regulated products.”
The State of Arkansas further bolstered the industries when the State of Arkansas legislated the establishment of the Arkansas Biosciences Institute (ABI) as a consortium of five research institutions: Arkansas Children’s Hospital (ACH); Arkansas State University (ASU); the University of Arkansas Division of Agriculture; the University of Arkansas, Fayetteville (UAF); and the University of Arkansas for Medical Sciences (UAMS).
One of the other efforts to bolster the industries was the establishment of the “Institute for Nanoscience & Engineering” research facility located on the University of Arkansas campus. The Institute comprises interdisciplinary departments across campus working in nanoscale research. Capabilities include materials growth and characterization, protein transportation, nano-bio photonics, theoretical modeling, tribology, and materials manufacturing. Successful federal funding, industry collaboration and support, and recruiting top notch faculty and students: For these reasons and more, the University of Arkansas Institute for Nanoscience & Engineering is at the forefront of research in nanoscience and nanotechnology.
Subsequently, the Institute for Nanoscience & Engineering established the “Arkansas Nano-Bio Materials Characterization Facility”. “The Facility provides state-of-art analytical services to the University and community with its high-resolution imaging, spectroscopy or sample preparation capabilities. The scientific activities cover a wide range of discipline ranging from Physics to Bio-Engineering and are aimed at supporting University research through the analysis of Nano and Bio materials properties down to the atomic scale.”